NO20002361L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO20002361L
NO20002361L NO20002361A NO20002361A NO20002361L NO 20002361 L NO20002361 L NO 20002361L NO 20002361 A NO20002361 A NO 20002361A NO 20002361 A NO20002361 A NO 20002361A NO 20002361 L NO20002361 L NO 20002361L
Authority
NO
Norway
Prior art keywords
adenosine
receptor
salts
chemical connections
solvates
Prior art date
Application number
NO20002361A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002361D0 (no
Inventor
Richard Peter Charles Cousins
Brian Cox
Colin David Eldred
Andrew Michael Kenneth Pennell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20002361D0 publication Critical patent/NO20002361D0/no
Publication of NO20002361L publication Critical patent/NO20002361L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20002361A 1997-11-08 2000-05-05 Kjemiske forbindelser NO20002361L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9723589.9A GB9723589D0 (en) 1997-11-08 1997-11-08 Chemical compounds
PCT/EP1998/007021 WO1999024449A2 (fr) 1997-11-08 1998-11-06 Composes chimiques

Publications (2)

Publication Number Publication Date
NO20002361D0 NO20002361D0 (no) 2000-05-05
NO20002361L true NO20002361L (no) 2000-07-05

Family

ID=10821760

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002361A NO20002361L (no) 1997-11-08 2000-05-05 Kjemiske forbindelser

Country Status (29)

Country Link
US (1) US6455510B1 (fr)
EP (2) EP1457495A1 (fr)
JP (1) JP2001522857A (fr)
KR (1) KR20010031875A (fr)
CN (1) CN1285843A (fr)
AP (1) AP2000001801A0 (fr)
AR (1) AR011229A1 (fr)
AT (1) ATE273990T1 (fr)
AU (1) AU2048399A (fr)
BR (1) BR9813976A (fr)
CA (1) CA2309200A1 (fr)
CO (1) CO5021135A1 (fr)
DE (1) DE69825780T2 (fr)
EA (1) EA200000392A1 (fr)
EE (1) EE200000285A (fr)
ES (1) ES2222621T3 (fr)
GB (1) GB9723589D0 (fr)
HR (1) HRP20000275A2 (fr)
HU (1) HUP0004082A2 (fr)
IL (1) IL135964A0 (fr)
IS (1) IS5477A (fr)
MA (1) MA26565A1 (fr)
NO (1) NO20002361L (fr)
PE (1) PE20000013A1 (fr)
PL (1) PL340921A1 (fr)
SK (1) SK6722000A3 (fr)
TR (1) TR200002131T2 (fr)
WO (1) WO1999024449A2 (fr)
ZA (1) ZA9810125B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
US20040162422A1 (en) * 2001-03-20 2004-08-19 Adrian Hall Chemical compounds
GB0106867D0 (en) 2001-03-20 2001-05-09 Glaxo Group Ltd Process
US6946449B2 (en) 2001-07-13 2005-09-20 Cv Therapeutics, Inc. Partial and full agonists of A1 adenosine receptors
US7157440B2 (en) 2001-07-13 2007-01-02 Cv Therapeutics, Inc. Partial and full agonists of A1 adenosine receptors
US7713946B2 (en) 2002-07-11 2010-05-11 Cv Therapeutics, Inc. Partial and full agonists A1 adenosine receptors
SG176313A1 (en) 2001-10-01 2011-12-29 Univ Virginia Patent Found 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US7265111B2 (en) 2002-06-27 2007-09-04 Sanofi-Aventis Deutschland Gmbh Adenosine analogues and their use as pharmaceutical agents
EP1375508A1 (fr) * 2002-06-27 2004-01-02 Aventis Pharma Deutschland GmbH Dérivés de l'adénosine N6-substitués et leur utilisation comme médicament
FR2842810B1 (fr) * 2002-07-25 2006-01-27 Inst Nat Sciences Appliq Nouveaux composes gem difluores, leur procedes de preparation et leurs applications.
NZ538590A (en) * 2002-08-15 2006-10-27 Cv Therapeutics Inc Partial and full agonists of A1 adenosine receptors
WO2004069185A2 (fr) 2003-02-03 2004-08-19 Cv Therapeutics Inc. Agonistes partiels et pleins des recepteurs a1 de l'adenosine
TW200519106A (en) 2003-05-02 2005-06-16 Novartis Ag Organic compounds
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
US7825126B2 (en) * 2004-09-09 2010-11-02 The United States Of America As Represented By The Department Of Health And Human Services Purine derivatives as A3 and A1 adenosine receptor agonists
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
WO2007045477A2 (fr) 2005-10-21 2007-04-26 Novartis Ag Molecules organiques
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
WO2007120972A2 (fr) * 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Procede permettant de traiter l'anemie a hematies falciformes
US8188063B2 (en) * 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
AU2007302263A1 (en) 2006-09-29 2008-04-03 Novartis Ag Pyrazolopyrimidines as P13K lipid kinase inhibitors
WO2008052734A1 (fr) 2006-10-30 2008-05-08 Novartis Ag Composés hétérocycliques en tant qu'agents anti-inflammatoires
US8058259B2 (en) * 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
EA201001135A1 (ru) * 2008-01-09 2011-02-28 ПиДжиИксХЭЛС ЭлЭлСи Интратекальное лечение невропатической боли агонистами ar
PT2231642E (pt) 2008-01-11 2014-03-12 Novartis Ag Pirimidinas como inibidores de quinase
WO2010088335A1 (fr) 2009-01-29 2010-08-05 Novartis Ag Benzimidazoles substitués destinés au traitement d'astrocytomes
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
BR112012003262A8 (pt) 2009-08-12 2016-05-17 Novartis Ag compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação
CN105078978A (zh) 2009-08-17 2015-11-25 因特利凯公司 杂环化合物及其用途
WO2011020861A1 (fr) 2009-08-20 2011-02-24 Novartis Ag Composés d'oximes hétérocycliques
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (fr) 2010-09-09 2012-03-15 Irm Llc Composés et compositions comme inhibiteurs de trk
US20130324526A1 (en) 2011-02-10 2013-12-05 Novartis Ag [1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
JP5808826B2 (ja) 2011-02-23 2015-11-10 インテリカイン， エルエルシー 複素環化合物およびその使用
CA2828219A1 (fr) 2011-02-25 2012-08-30 Irm Llc Composes et compositions en tant qu'inhibiteurs de trk
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
CA2848809A1 (fr) 2011-09-15 2013-03-21 Novartis Ag 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines substituees en position 6 a activite tyrosine kinase
EP2793893A4 (fr) 2011-11-23 2015-07-08 Intellikine Llc Régimes de traitement améliorés utilisant des inhibiteurs de mtor
WO2013149581A1 (fr) 2012-04-03 2013-10-10 Novartis Ag Produits combinés comprenant des inhibiteurs de tyrosine kinase et leur utilisation
CN105246482A (zh) 2013-03-15 2016-01-13 因特利凯有限责任公司 激酶抑制剂的组合及其用途
WO2015084804A1 (fr) 2013-12-03 2015-06-11 Novartis Ag Combinaison d'un inhibiteur de mdm2 et d'un inhibiteur de braf, et leur utilisation
WO2016011658A1 (fr) 2014-07-25 2016-01-28 Novartis Ag Polythérapie
WO2016016822A1 (fr) 2014-07-31 2016-02-04 Novartis Ag Polythérapie
TW202140550A (zh) 2020-01-29 2021-11-01 瑞士商諾華公司 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575959A (en) * 1969-05-13 1971-04-20 Merck & Co Inc 5'-substituted ribofuranosyl nucleosides
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
WO1997033591A1 (fr) * 1996-03-13 1997-09-18 Novo Nordisk A/S Procede de traitement d'affections associees aux cytokines chez les mammiferes
GB9610031D0 (en) * 1996-05-14 1996-07-17 Glaxo Group Ltd Chemical compounds
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
PE20000013A1 (es) 2000-01-21
MA26565A1 (fr) 2004-12-20
HUP0004082A2 (hu) 2001-04-28
DE69825780D1 (de) 2004-09-23
HRP20000275A2 (en) 2000-12-31
GB9723589D0 (en) 1998-01-07
DE69825780T2 (de) 2005-01-13
ATE273990T1 (de) 2004-09-15
BR9813976A (pt) 2000-09-26
ZA9810125B (en) 2000-05-05
AR011229A1 (es) 2000-08-02
CA2309200A1 (fr) 1999-05-20
AU2048399A (en) 1999-05-31
JP2001522857A (ja) 2001-11-20
AP2000001801A0 (en) 2000-06-30
ES2222621T3 (es) 2005-02-01
US6455510B1 (en) 2002-09-24
PL340921A1 (en) 2001-03-12
IL135964A0 (en) 2001-05-20
EA200000392A1 (ru) 2000-12-25
WO1999024449A2 (fr) 1999-05-20
KR20010031875A (ko) 2001-04-16
SK6722000A3 (en) 2001-01-18
TR200002131T2 (tr) 2001-01-22
CN1285843A (zh) 2001-02-28
EP1030857B1 (fr) 2004-08-18
EP1030857A2 (fr) 2000-08-30
CO5021135A1 (es) 2001-03-27
WO1999024449A3 (fr) 1999-08-19
NO20002361D0 (no) 2000-05-05
EE200000285A (et) 2001-08-15
IS5477A (is) 2000-05-03
EP1457495A1 (fr) 2004-09-15

Similar Documents

Publication Publication Date Title
NO20002361L (no) Kjemiske forbindelser
NO20002360L (no) Kjemiske forbindelser
WO1999024451A3 (fr) Composes chimiques
CO5040216A1 (es) Agonistas de adenosina a 1, proceso para su preparacion y composiciones farmaceuticas que los contienen
EA200000683A1 (ru) Производные ряда 4-(2-кето-1-бензимидазолинил)пиперидина в качестве агонистов orl1-рецептора
PA8484201A1 (es) Derivados de adenina
PT933363E (pt) Pirazoles parasiticidas
ES548357A0 (es) Procedimiento para preparar derivados de n-(adamantil-1)-pirrolidon-5-carboxamida-2.
ES2087103T3 (es) Procedimiento para la determinacion especifica de la alfa-amilasa del pancreas.
ES2046496T3 (es) Procedimiento para la preparacion de agentes de hidroxialquilacion, los nuevos agentes asi obtenidos y su empleo.
NO834566L (no) Fremgangsmaate ved fremstilling av imidazolderivater
DK0381628T3 (da) Glycocyamidinderivater
AR245721A1 (es) Procedimiento para preparar un derivado 27-halo de compuestos ll-f28249 y composicion para controlar insectos que lo comprende.
ES2062223T3 (es) Derivados de imidazol, procedimiento para la preparacion de los mismos y agentes antiulcera que los contienen.
RU93004729A (ru) Новые производные имидазола
ES531252A0 (es) Procedimiento para la obtencion de iminosulfonamidas
DK5984D0 (da) 1-(3,4-bis-(3-(lavere alkoxycarbonyl)-2-thioureido)phenyl)-1-phenylethylener
ES8706642A1 (es) Procedimiento para la obtencion de compuestos de urea

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application